Anticancer drugs induce necrosis of human endothelial cells involving both oncosis and apoptosis

European Journal of Cell Biology

Volumn 80, Issue 6, 2001, Pages 442-449

  Mailloux, Agnès ^a,b   Grenet, Karine ^a   Bruneel, Arnaud ^a,b   Bénéteau Burnat, Bénédicte ^a   Vaubourdolle, Michel ^a   Baudin, Bruno ^a,b  

^a HÔPITAL SAINT ANTOINE   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Apoptosis; B cells leukemia 2 protein; Cancer chemotherapy; Endothelium; Oxidative stress

Indexed keywords

ANGIOTENSIN I; ANTINEOPLASTIC AGENT; BLEOMYCIN; DIPEPTIDYL CARBOXYPEPTIDASE; DNA FRAGMENT; DOXORUBICIN; ETOPOSIDE; LACTATE DEHYDROGENASE; MALONALDEHYDE; PACLITAXEL; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53;

APOPTOSIS; ARTICLE; CELL CULTURE; CELL DEATH; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; ENDOTHELIUM CELL; ENZYME LOCALIZATION; ENZYME RELEASE; HUMAN; HUMAN CELL; IMMUNOBLOTTING; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SUPERNATANT; TUMOR VASCULARIZATION; UMBILICAL VEIN; VASCULAR ENDOTHELIUM;

EID: 0034949453     PISSN: 01719335     EISSN: None     Source Type: Journal    
DOI: 10.1078/0171-9335-00171     Document Type: Article

References (41)

1. Effects of injury and repair of the pulmonary endothelium on lung metastasis after bleomycin
2. Toxicité endothéliale des chimiothérapies anti-cancéreuses
3. Cytotoxicity of amiodarone in cultured human endothelial cells
4. Vascular origin determines angiotensin I-converting enzyme expression in endothelial cells
5. Radiometric determination of angiotensin I-converting enzyme activity in human broncho-alveolar lavage and cerebrospinal fluids and in aqueous humor for the management of sarcoidosis
6. The binding of some human anti-endothelial cell antibodies induces endothelial cell apoptosis
7. Endostatin induces endothelial cell apoptosis
8. Endothelial cell apoptosis in angiogenesis and vessel regression
9. Comment l'endothélium participe-t-il au contrôle du tonus vasculaire?
10. Apoptosis in cancer therapy: Crossing the threshold
11. Modulation of apoptotic cell death by extracellular matrix proteins and a fibronectin-derived anti-adhesive peptide
12. Nonlinear pharmacokinetics and metabolism of paclitaxel and its pharmacokinetic/pharmacodynamic relationships in humans
13. Nitric oxide and peroxynitrite-mediated pulmonary cell death
14. Endothelial control of the cardiovascular system: Recent advances
15. Fragments of amyloid β induce apoptosis in vascular endothelial cells
16. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria
17. Apoptosis induced by lack of hemodynamic forces is a general endothelial feature even occurring in immortalized cells lines
18. Suppression by metallothionein of doxorubicin-induced cardiomyocyte apoptosis through inhibition of p38 mitogen-activated protein kinases
19. Tumor necrosis factor and endothelial cell death
20. Pharmacokinetics and bioequivalence of etoposide following intravenous administration of etoposide phosphate and etoposide in patients with solid tumors
21. Induction of endothelial cell apoptosis by solid tumor cells
22. Doxorubicin (adriamycin): A critical review of free radical-dependent mechanisms of cytotoxicity
23. "Accidental" anti-angiogenic drugs: Anti-oncogene directed signal transduction inhibitors and conventional chemotherapeutic agents as examples
24. The pharmacokinetics of bleomycin in man
25. Endothelial injury caused by antineoplastic agents
26. Bleomycin inhibition of angiotensin-converting enzyme activity from serum, lungs and cultured pulmonary artery endothelial cells
27. Dual modes of death induced by etoposide in human epithelial tumor cells allow Bcl-2 to inhibit apoptosis without affecting clonogenic survival
28. Requirement of nitric oxide and calcium mobilization for the induction of apoptosis in adrenal vascular endothelial cells
29. Suppression of apoptosis by inhibition of phosphatidylcholine-specific phospholipase C in vascular endothelial cells
30. Vascular endothelial growth factor (VEGF)-mediated angiogenesis is associated with enhanced endothelial cell survival and induction of bcl-2 expression
31. Bcl-2 heterodimerizes in vivo with a conserved homolog, bax, that accelerates programmed cell death
32. Mitochondria and programmed cell death: Beck to the future
33. Adriamycin and daunomycin induce programmed cell death (apoptosis) in tumour cells
34. Effects of bis-chloronitrosourea (BCNU) on pulmonary and serum angiotensin-converting enzyme activity in rats
35. Mechanisms of hypoxia-induced endothelial cell death. Role of p53 in apoptosis
36. Endothelial dysfunction in a rat model of endotoxic shock
37. Upregulated expression of Bcl-2 in multiple myeloma cells induced by exposure to doxorubicin, etoposide, and hydrogen peroxide
38. Topoisomerase II-reactive chemotherapeutic drugs induce apoptosis in thymocytes
39. Induction of heat shock protein 72 prevents neutrophil-mediated human endothelial cell necrosis
40. Pharmacokinetic profile of high-dose doxorubicin administered during a 6h intravenous infusion in breast cancer patients
41. Pharmacokinetic analysis of high-dose toremifene in combination with doxorubicin